Lower plasma CC16, a natural anti-inflammatory protein, and increased plasma interleukin-1 receptor antagonist in schizophrenia: Effects of antipsychotic drugs

Schizophrenia Research

Volumn 21, Issue 1, 1996, Pages 39-50

  Maes, Michael ^a,b   Bosmans, Eugene ^c   Ranjan, Rakesh ^a   Vandoolaeghe, Eric ^b   Meltzer, Herbert Y ^d   De Ley, Marc ^d   Berghmans, Raf ^c   Stans, Greet ^d   Desnyder, Roger ^b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b Clinical Research Center for Mental Health of Antwerp   (Belgium)

^c Eurogenetics   (Belgium)

^d UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Clara cell protein; Cytokines; Interleukin 1 receptor antagonist; Interleukin 2 receptor; sCD8; Schizophrenia; Suppressor cytotoxic

Indexed keywords

CC16 PROTEIN; CELL PROTEIN; HALOPERIDOL; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 2 RECEPTOR; LOXAPINE; PHENOTHIAZINE DERIVATIVE; RISPERIDONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELLULAR IMMUNITY; CLARA CELL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; RECEPTOR BLOCKING; RECEPTOR SOLUBILIZATION; SCHIZOPHRENIA; T LYMPHOCYTE ACTIVATION;

EID: 0030608072     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/0920-9964(96)00029-1     Document Type: Article

References (75)

1. American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: The American Psychiatric Association.
2. Aukrust, P., Muller, F. and Froland, S.S. (1994) Elevated serum levels of interleukin-4 and interleukin-6 in patients with common variable immunodeficiency (CVI) are associated with chronic immune activation and low numbers of CD4 + lymphocytes. Clin. Immunol. Immunopathol. 70, 217-224.
3. Aurelius, E., Andersson, B., Forsgren, M., Skoldenberg, B. and Strannegard, O. (1994) Cytokines and other markers of intrathecal immune response in patients with herpes simplex encephalitis. J. Infect. Dis. 170, 678-681.
4. Baker, G.A., Santalo, R. and Blumenstein, J. (1977) Effect of psychotropic agents upon the blastogenic response of human T-lymphocytes. Biol. Psychiatry 12, 159-169.
5. Becker, H., Paul, E., Schaum, S., Renelt, M. and Federlin, K. (1992) Circulating CD8 as an indicator of inflammatory rheumatic disease. Immun. Infekt. 20, 6-9.
6. Bernard, A., Roels, H., Lauwerys, R., Witters, R., Gielens, C., Soumillion, A., Van Damme, J. and De Ley, M. (1992) Human urinary protein 1: evidence for identity with the Clara cell protein and occurrence in respiratory tract and urogenital secretions. Clin. Chim. Acta 15, 239-249.
7. Bock, G.R., Marsh, J. and Widdows, K. (1992) Polyfunctional Cytokines: IL-6 and LIF, Ciba Foundation Symposium 167. John Wiley and Sons, Chichester.
8. Boukhris, W., Kouassi, E. and Revillard, J.P. (1988) Differential effect of mixed D1/D2 and selective D2 dopaminergic antagonists on mouse T and B lymphocyte proliferation and interleukin production in vitro. Immunopharmacol. Immunotoxicol. 10, 501-512.
9. Caruso, C., Candore, G., Cigna, D., Colucci, A.T. and Modica, M. A. (1993) Biological significance of soluble IL-2 receptor. Med. Inflamm. 2, 3-21.
10. Dayer, J.-M. and Burger, D. (1994) Interleukin-1, tumor necrosis factor and their specific inhibitors. Eur. Cytokine Netw. 5, 563-571.
11. DeLisi, L.E., Weber, R.J. and Pert, C.B. (1985) Are there antibodies against brain in sera from schizophrenic patients? Biol. Psychiatry 20, 94-119.
12. de Paoli, P., Gennari, D., Reitano, M., Martelli, P., Sacilotto, C., Comoretto, R. and Santini, G. (1991) CD8 lymphocytes during Epstein-Barr virus (EBV) infection: a CD29 positive population is expanded in acute infectious mononucleosis. Allergol. Immunopathol. Madr. 19, 95-97.
13. Descotes, J. and Evreux, J.C. (1981) Depressant effects of major tranquilizers on contact sensitivity to picryl chloride in the mouse. Experentia 37, 1004.
14. Di Cesare, E., Previti, M., Ingemi, M.C., Bagnato, G.F. and Cucinotta, D. (1994) High serum levels of soluble CD8 in insulin-dependent diabetes. Clin. Exp. Immunol. 95, 283-286.
15. Dierynck, I., Bernard, A., Roels, H. and De Ley, M. (1995) Potent inhibition of both interferon-γ production and biologic activity by the Clara cell protein CC16. Am. J. Respir. Cell. Mol. Biol. 12, 205-210.
16. Dinarello, C.A. (1994) The biological properties of interleukin-1. Eur. Cytokine Netw. 5, 517-531.
17. Dripps, D.J., Brandhuber, B.J., Thompson, R.C. and Eisenberg, S.P. (1991) Interleukin-1 (IL1) receptor antagonist binds to the 80-kDa IL-1 receptor but does not initiate IL-1 signal transduction. J. Biol. Chem. 266, 10331-10338.
18. El-Mallakh, R.S., Suddath, R.I. and Wyatt, R.J. (1993) Interleukin-1α and interleukin-2 in cerebrospinal fluid of schizophrenic subjects. Progr. NeuroPsychopharmacol. Biol. Psychiatry 17, 383-391.
19. Endicott, J. and Spitzer, R.L. (1978) A diagnostic interview; the schedule for affective disorders and schizophrenia. Arch. Gen. Psychiatry 835, 837-844.
20. Fuchs, D., Samsonov, M., Tilz, G.P., Reibnegger, G., Belenkov, J.N., Nassonov, E.L. and Wachter, H. (1993) Stimulated cellular immune system in patients with congestive heart failure. Eur. J. Clin. Chem. Clin. Biochem. 31, 111-114.
21. Ganguli, R. and Rabin, B.S. (1989) Increased serum interleukin-2 receptor concentration in schizophrenic and brain damaged subjects. Arch. Gen. Psychiatry 46, 292.
22. Ganguli, R., Brar, J.S., Solomon, W., Chengappa, K.N.R. and Rabin, B.S. (1992) Altered interleukin-2 production in schizophrenia: association between clinical state and autoantibody production. Psychiatr. Res. 44, 113-123.
23. Ganguli, R., Yang, Z., Shurin, G., Chengappa, K.N.R., Brar, J.S., Gubbi, A.V. and Rabin, B.S. (1994) Serum interleukin-6 concentration in schizophrenia: elevation associated with duration of illness. Psychiatr. Res. 51, 1-10.
24. Henneberg, A., Riedl, B., Dumke, H.-O. and Kornhuber, H.H. (1990) T-lymphocyte subpopulations in schizophrenic patients. Eur. Arch. Psychiatr. Clin. Neurosci. 239, 283-284.
25. Hornung, N., Raskova, J., Raskta, K. and Degiannis, D. (1992) IL-2 responsiveness of lectin-induced lymphoblasts: soluble IL-2 receptor release and differential in vitro effects of immunosuppressants. Int. J. Immunopharmacol. 14, 753-760.
26. Johnson, G., Brane, D., Block, W. et al. (1992) Cerebrospinal fluid protein variations in common to Alzheimer's disease and schizophrenia. Appl. Theoret. Electrophoresis 3, 47-53.
27. Kim, H.S., Degiannis, D., Raskova, J. and Raska, K. (1991) Cyclosporine A and prednisolone inhibit lectin- and alloantigen-induced release of sCD8: correlation with proliferative responses. Clin. Immunol. Immunopathol. 60, 27-39.
28. Kirch, D.G. (1993) Infection and autoimmunity as etiologic factors in schizophrenia: a review and reappraisal. Schizophr. Bull. 19, 355-370.
29. Lewis, D.B. and Wilson, C.B. (1990) Gamma interferon: an immunoregulatory lymphokine with immunotherapeutic potential. Pediatr. Infect. Dis. 9, 642-651.
30. Licinio, J., Krystal, J.H., Seibyl, J.P., Altemus, M. and Charney, D.S. (1991) Elevated central levels of interleukin-2 in drug-free schizophrenic patients. Schizophr. Res. 44, 372.
31. Linker-Israeli, M., Hyun, S., Ozeri-Chen, T., Wallace, D.J., Banks, K. and Klinenberg, J.R. (1994) Elevated in vivo and in vitro secretion of CD8-alpha molecules in patients with systemic lupus erythematosus. J. Immunol. 152, 3158-3167.
32. Lipnick, R.N., Sfikakis, P.P., Klipple, G.L. and Tsokos, G.C. (1993) Elevated soluble CD8 antigen and soluble interleukin-2 receptors in the sera of patients with juvenile rheumatoid arthritis. Clin. Immunol. Immunopathol. 68, 64-67.
33. McAllister, C.G., Rapaport, M.H., Pickar, D. and Paul, S.M. (1989) Effects of short-term administration of antipsychotic drugs on lymphocyte subsets in schizophrenic patients. Arch. Gen. Psychiatry 46, 956-957.
34. McAllister, C.G., Rapaport, M.H., Pickar, D. and Paul, S.M. (1991) Autoimmunity and schizophrenia. In: C.A. Tamminga and S.C. Schultz (Eds.), Advances in Neuropsychiatry and Psychopharmacology, Volume 1: Schizophrenia Research. Raven Press, New York, pp. 111-118.
35. Macs, M., Scharpé, S., Meltzer, H.Y., Bosmans, E., Suy, E., Calabrese, J. and Cosyns, P. (1993) Relationships between interleukin-6 activity, acute phase proteins and HPA-axis function in severe depression. Psychiatr. Res. 49, 11-27.
36. Maes, M., Meltzer, H.Y. and Bosnians, E. (1994) Immune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine. Acta Psychiatr. Scand. 89, 346-351.
37. Maes, M., Bosmans, E., Calabrese, J., Smith, R. and Meltzer, H.Y. (1995a) Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers. J. Psychiatr. Res. 29, 141-152.
38. Maes, M., Meltzer, H.Y., Buckley, P. and Bosmans, E. (1995b) Plasma soluble interleukin-2 and transferrin receptor in schizophrenia and depression. Eur. Arch. Psychiatr. Clin. Sci. 244, 325-329.
39. Maes, M., Delanghe, J., Ranjan, R., Meltzer, H.Y., Desnyder, R., Cooreman, W. and Scharpe, S. (1996) The acute phase protein response in schizophrenia, mania and major depression: effects of psychotropic drugs. Psychiatr. Res. in press.
40. Mantile, G., Miele, L., Cordella-Miele, E., Singh, G., Katyal, S.L. and Mukherjee, A.B. (1993) Huamn Clara cell 10-kDa protein is the counterpart of rabbit uterogtobin. J. Biol. Chem. 268, 20343-20351.
41. Margraf, L.R., Finegold, M.J., Stanley, L.A., Major, A., Hawkins, H.K. and DeMayo, F.J. (1993) Cloning and tissue-specific expression of the cDNA for the mouse Clara cell 10 kD protein: comparison of endogenous expression to rabbit uteroglobin promotor-driven transgene expression. Am. J. Respir. Cell. Mol. Biol. 9, 231-238.
42. Meltzer, H.Y. (1995) Atypical antipsychotic drugs. In: F.E. Bloom and D.J. Kupfer (Eds.), Psychopharmacology, the Fourth Generation of Progress. Raven Press, New York, pp. 1277-1286.
43. Miele, L., Cordella-Miele, E. and Mukherjee, A.B. (1987) Uteroglobin: structure, molecular biology, and new perspectives on its function as a phospholipase A2 inhibitor. Endocr. Rev. 8, 474-490.
44. Monteleone, P., Valente, B., Maj, M. and Kemali, D. (1991) Reduced lymphocyte response to PHA and OKT3 in drug-free and neuroleptic treated chronic schizophrenics. Biol. Psychiatry 30, 201-204.
45. Motohashi, T. (1993) Serum soluble CD2, CD4 and CD8 levels in infectious mononucleosis. Arerugi 42, 926-933.
46. Mullberg, J., Schooltink, H., Stoyan, T., Gunther, M., Graeve, L., Buse, G., Mackiewicz, A., Heinrich, P.C. and Rose-John, S. (1993) The soluble interleukin-6 receptor is generated by shedding. Eur. J. Immunol. 23, 473-480.
47. Muller, N., Ackenheil, M., Hofschuster, E., Mempel, W. and Eckstein, R. (1991) Cellular immunity in schizophrenic patients before and during neuroleptic treatment. Psychiatry Res. 37, 147-160.
48. Muller, N., Hofschuster, E., Ackenheil, M. and Eckstein, R. (1993) T-cells and psychopathology in schizophrenia: relationship to the outcome of neuroleptic therapy. Acta Psychiatr. Scand. 87, 66-71.
49. Nahas, G.G., Desoize, B. and Leger, C. (1979) Effects of psychotropic drugs on DNA synthesis in cultured lymphocytes (40447). Proc. Soc. Exp. Biol. Med. 160, 344-348.
50. Pandey, R.S., Gupta, A.K. and Chaturvedi, U.C. (1981) Autoimmune model of schizophrenia with special reference to antibrain antibodies. Biol. Psychiatry 16, 1123-1136.
51. Peri, A., Cordella-Miele, E., Miele, L. and Mukherjee, A.B. (1993) Tissue specific expression of the gene coding for human Clara cell 10-kDa protein, a phospholipase A2-inhibitory protein. J. Clin. Invest. 92, 2099-2109.
52. Pestka, S., Langer, L.A., Zoon, K.C. and Samuel, C.E. (1987) Interferons and their actions. Annu. Rev. Biochem. 56, 727-777.
53. Rapaport, M.H., McAllister, C.G., Pickar, D., Nelson, D.L. and Paul, S.M. (1989) Elevated levels of soluble interleukin-2 receptors in schizophrenia. Arch. Gen. Psychiatry 46, 291-292.
54. Rapaport, M.H., McAllister, C G., Kirch, D.G. and Pickar, D. (1990) The effect of typical and atypical neuroleptics on mitogen-induced T-lymphocyte responsiveness. Biol. Psychiatry 29, 715-717.
55. Rhoades, H.M. and Overall, J.E. (1988) The semistructured BPRS interview and rating guide. Psychopharmacol. Bull. 10, 101-104.
56. Roth, B. and Meltzer, H.Y. (1995) The role of serotonin in schizophrenia. In: F.E. Bloom and D.J. Kupfer (Eds.), Psychopharmacology, the Fourth Generation of Progress. Raven Press, New York, pp. 1215-1227.
57. Roux-Lombard, P., Modoux, C. and Dayer, J.M. (1989) Production of interleukin-1 (IL-1) and a specific IL-1 inhibitor during human monocyte-macrophage differentiation: influence of GM-CSF. Cytokine 45-52.
58. Sawada, S., Hashimoto, H., Iijima, S., Tokano, Y., Takei, M., Shida, M. and Obara, T. (1993) Immunologic significance of increased soluble CD8/CD4 molecules in patients with active systemic lupus erythematosus. J. Clin. Lab. Anal. 7, 141-146.
59. Schlesinger, M., Chu, F.N., Badamchian, M., Jiang, J.D., Roboz, J.P., Goldstein, A.L. and Bekesi, J.G. (1994) A distinctive form of soluble CD8 is secreted by stimulated CD8 + cells in HIV-1-infected and high-risk individuals. Clin. Immunol. Immunopathol. 73, 252-260.
60. Schleuning, M.J., Duggan, A. and Reem, G.H. (1989) Inhibition by chlorpromazine of lymphokine-specific mRNA expression in human thymocytes. Eur. J. Immunol. 19, 1491-1496.
61. Shintani, F., Kanba, S., Maruo, N., Nakaki, T., Nibuga, M., Suzuki, E., Kinoshita, N. and Yagi, G. (1991) Serum interleukin-6 in schizophrenic patients. Life Sci. 49, 661-664.
62. Sims, J.S. and Dower, S.K. (1994) Interleukin-1 receptors. Eur. Cytokine Netw. 5, 539-546.
63. Singh, G. and Katyal, S.L. (1984) An immunological study of the secretory products of rat Clara cells. J. Histochem. Cytochem. 32, 49-54.
64. Singh, G., Katyal, S.L., Brown, W.E., Kennedy, A.L., Singh, U. and Wong-Chong, M.L. (1990) Clara cell 10 kDa protein (CC10): comparison of structure and function to utero globin. Biochim. Biophys. Acta 1039, 348-355.
65. Sirota, P., Schild, K., Elizur, A., Djaldetti, M. and Fishman, P. (1995) Increased interleukin-1 and interleukin-3 like activity in schizophrenic patients. Progr. NeuroPsychopharmacol. Biol. Psychiatry 19, 75-83.
66. Smidt, E., Axelsson, R. and Steen, G. (1988) Treatment of chronic schizophrenia with glucocorticoids in combination with neuroleptic drugs: a pilot study. Curr. Ther. Res. 43, 842-850.
67. Smith, R.S. (1991) Is schizophrenia caused by excessive production of interleukin-2 and interleukin-2 receptors by gastrointestinal lymphocytes? Med. Hypoth. 34, 225-229.
68. Smith, R.S. (1992) A comprehensive macrophage-T-lymphocyte theory of schizophrenia. Med. Hypoth. 39, 248-257.
69. Smith, R. and Maes, M. (1995) The macrophage-T-lymphocyte theory of schizophrenia: additional evidence. Med. Hypoth. in press.
70. Tomkinson, B.E., Brown, M.C., Ip, S.H., Carrabis, S. and Sullivan, J.L. (1989) Soluble CD8 during T cell activation. J. Immunol. 142, 2230-2236.
71. van Kammen, D.P., McAllister, C., Yao, J.K. et al. (1994) A clinical and biochemical model of relapse prediction in schizophrenia: a role for CSF interleukin 2? Schizophr. Res. 11, 128.
72. Villemain, F., Chatenoud, L., Galinowski, A., Homo-Delarche, F., Ginestet, D., Loo, H., Zarifian, E. and Bach, J.F. (1989) Aberrant T cell-mediated immunity in untreated schizophrenic patients: deficient interleukin-2 production. Am. J. Psychiatry 146, 609-616.
73. Wijngaard, P.L., Van der Meulen, A., Gmelig Meyling, F.H., De Jonge, N. and Schuurman, H.J. (1994) Soluble CD8 and CD25 in serum of patients after heart transplantation. Clin. Exp. Immunol. 97, 505-509.
74. Wolf, M., Klug, J., Haekenbergr, R., Gessler, M., Grzesehik, K.H., Beato, M. and Suske, G. (1992) Human CC10, the homologue of rabbit uteroglobin: genomic cloning, chromosomal localization and expression in endometrial cell lines. Hum. Mol. Genet. 1, 371-378.
75. Wolvekamp, M.C.J. and Marquet, R.L. (1990) Interleukin-6: historical background, genetics and biological significance. Immunol. Lett. 24, 1-10.